Cargando…

Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening

Methylated SEPT9 showed relatively low sensitivity in detecting early stage colorectal cancer (CRC) and advanced adenomas (AA) in plasma. Combination of multiple biomarkers was an effective strategy to improve sensitivity in early stage cancer diagnosis and screening. A new qPCR‐based assay combinin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Guodong, Li, Hui, Yang, Zixuan, Wang, Zhenzhen, Xu, Manqiu, Xiong, Shangmin, Li, Shiming, Wu, XiaoTing, Liu, Xiaoyu, Wang, Ziwen, Zhu, Yun, Ma, Yong, Fei, Sujuan, Zheng, Minxue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745865/ https://www.ncbi.nlm.nih.gov/pubmed/31407497 http://dx.doi.org/10.1002/cam4.2475

Ejemplares similares

Performance Comparison Between Plasma and Stool Methylated SEPT9 Tests for Detecting Colorectal Cancer
por: Liu, Yi, et al.
Publicado: (2020)

Blood leukocytes methylation levels analysis indicate methylated plasma test is a promising tool for colorectal cancer early detection
por: Chen, Zhiliang, et al.
Publicado: (2021)

Feasibility of Plasma-Methylated SFRP2 for Early Detection of Gastric Cancer
por: Miao, Jin, et al.
Publicado: (2020)

Aberrant DNA Methylation of SEPT9 and SDC2 in Stool Specimens as an Integrated Biomarker for Colorectal Cancer Early Detection
por: Zhao, Guodong, et al.
Publicado: (2020)

A simplified multiplex methylated DNA testing for early detection of colorectal cancer in stool DNA
por: Dai, Yanmiao, et al.
Publicado: (2022)

Methylated SFRP2 and SDC2 in stool specimens for Colorectal Cancer early detection: A cost-effective strategy for Chinese population
por: Zhao, Guodong, et al.
Publicado: (2021)

KCNQ5 and C9orf50 Methylation in Stool DNA for Early Detection of Colorectal Cancer
por: Cao, Yaping, et al.
Publicado: (2021)

A Novel Plasma-Based Methylation Panel for Upper Gastrointestinal Cancer Early Detection
por: Peng, Cheng, et al.
Publicado: (2022)

Feasibility of Methylated CLIP4 in Stool for Early Detection of Colorectal Cancer: A Training Study in Chinese Population
por: Cao, Yang, et al.
Publicado: (2021)

A sensitive and robust plasma-based DNA methylation panel for early detection of target gastrointestinal cancers
por: Dai, Yanmiao, et al.
Publicado: (2023)

Identifying potential DNA methylation markers for the detection of esophageal cancer in plasma
por: Pei, Bing, et al.
Publicado: (2023)

Combining Serum DNA Methylation Biomarkers and Protein Tumor Markers Improved Clinical Sensitivity for Early Detection of Colorectal Cancer
por: Zhang, Guoying, et al.
Publicado: (2021)

Real‐world application of a fast stool DNA test for colorectal cancer screening in primary screening positive population
por: Zhu, Yunfeng, et al.
Publicado: (2022)

Methylated SEPTIN9 plasma test for colorectal cancer detection may be applicable to Lynch syndrome
por: Hitchins, Megan P, et al.
Publicado: (2019)

Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer
por: Su, Wei-Chih, et al.
Publicado: (2021)

Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in oligodendroglial tumors
por: Kuo, Lu‐Ting, et al.
Publicado: (2016)

Performance of a Novel Blood-Based Early Colorectal Cancer Screening Assay in Remaining Serum after the Blood Biochemical Test
por: Chen, Ying, et al.
Publicado: (2019)

The pivotal role of DNA methylation in the radio‐sensitivity of tumor radiotherapy
por: Zhu, Xueru, et al.
Publicado: (2018)

DNA Methylation-Based Testing in Peripheral Blood Mononuclear Cells Enables Accurate and Early Detection of Colorectal Cancer
por: Xie, Yan, et al.
Publicado: (2023)

Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patients
por: Takane, Kiyoko, et al.
Publicado: (2014)

Multiplex determination of serological signatures in the sera of colorectal cancer patients using hydrogel biochips
por: Butvilovskaya, Veronika I., et al.
Publicado: (2016)

Plasma metabolites associated with colorectal cancer: A discovery‐replication strategy
por: Geijsen, Anne J.M.R., et al.
Publicado: (2019)

Cooperation of SRPK2, Numb and p53 in the malignant biology and chemosensitivity of colorectal cancer
por: Wang, Guosen, et al.
Publicado: (2020)

Differentially expressed lncRNAs and mRNAs identified by NGS analysis in colorectal cancer patients
por: Li, Meng, et al.
Publicado: (2018)

Screening of immunosuppressive cells from colorectal adenocarcinoma and identification of prognostic markers
por: Li, Fazhan, et al.
Publicado: (2021)

Plasma metabolites associated with colorectal cancer stage: Findings from an international consortium
por: Geijsen, Anne J.M.R., et al.
Publicado: (2019)

DNA methylation‐regulated and tumor‐suppressive roles of miR‐487b in colorectal cancer via targeting MYC, SUZ12, and KRAS
por: Chen, Xu, et al.
Publicado: (2019)

Methylation of three genes encoded by X chromosome in blood leukocytes and colorectal cancer risk
por: Tian, Tian, et al.
Publicado: (2021)

Long non-coding RNA ROR1-AS1 induces tumorigenesis of colorectal cancer by affecting Wnt/β-catenin signaling pathway
por: Wang, Wei, et al.
Publicado: (2019)

More evidence for prediction model of radiosensitivity
por: Du, Zixuan, et al.
Publicado: (2021)

MiRNA-574-3p inhibits cell progression by directly targeting CCND2 in colorectal cancer
por: Li, Wen-Cui, et al.
Publicado: (2019)

RAPTOR promotes colorectal cancer proliferation by inducing mTORC1 and upregulating ribosome assembly factor URB1
por: Wang, Tao, et al.
Publicado: (2019)

miR-125 inhibits colorectal cancer proliferation and invasion by targeting TAZ
por: Yang, Meiyuan, et al.
Publicado: (2019)

Colorectal cancer (CRC) as a multifactorial disease and its causal correlations with multiple signaling pathways
por: Wan, Mao-lin, et al.
Publicado: (2020)

Alcohol consumption, blood DNA methylation and breast cancer: a Mendelian randomisation study
por: Zhou, Xuan, et al.
Publicado: (2022)

Characteristics of colorectal carcinoma patients with PMS2 defects detected by immunohistochemistry
por: Zeng, Zhijun, et al.
Publicado: (2020)

The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer
por: Kodach, Liudmila L., et al.
Publicado: (2010)

Plasma microRNA-720 may predict prognosis and diagnosis in glioma patients
por: Chen, Peng, et al.
Publicado: (2020)

Plasma protein expression differs between colorectal cancer patients depending on primary tumor location
por: Holm, Matilda, et al.
Publicado: (2020)

Mismatch repair status between primary colorectal tumor and metastatic tumor, a retrospective consistent study
por: Wang, Zheng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tj2278npj16v0oenaajs7lsr4t